London, United Kingdom

Nadine Hall

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Akos Biosciences, Inc.. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nadine Hall: Innovator in Cancer Therapeutics

Introduction

Nadine Hall is a prominent inventor based in London, GB. She has made significant contributions to the field of cancer therapeutics, particularly in the treatment of breast cancer. Her innovative approach combines cannabinoids with chemotherapeutic agents to enhance treatment efficacy.

Latest Patents

Nadine Hall holds a patent for a groundbreaking invention titled "Combination of a cannabinoid and a chemotherapeutic agent for the treatment of breast cancer." This patent highlights the finding that administering cannabinoids after a chemotherapeutic agent can lead to lower cancer cell viability compared to using the chemotherapeutic agent alone. The pharmaceutical composition she developed involves a two-phase treatment process, where the chemotherapeutic agent is administered first, followed by the cannabinoid.

Career Highlights

Nadine Hall's career is marked by her dedication to advancing cancer treatment methodologies. Her work has the potential to improve outcomes for breast cancer patients significantly. She is associated with Akos Biosciences, Inc., where she continues to innovate in the field of cancer therapeutics.

Collaborations

Nadine collaborates with esteemed colleagues such as Angus Dalgleish and Wai Liu. Their combined expertise contributes to the advancement of research in cancer treatment.

Conclusion

Nadine Hall's innovative work in combining cannabinoids with chemotherapeutic agents represents a significant advancement in cancer therapeutics. Her contributions are paving the way for more effective treatments for breast cancer patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…